ACORN CAPITAL ADVISORS, LLC
CIK 2054410 · View on SEC EDGAR ↗
- Portfolio value
- $366.5M
- Positions
- 20
- As of
- June 30, 2026
#4,596 of 9,443 by 13F value · top 48.7%
Portfolio value QoQ: +4.2% 13F does not disclose cash
- Top 10 holdings weight
- 90.19%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 15
- Effective number of positions
- 8.5
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 5.88% Est. buys $21,112,022 · sells $119,078,762
Median holding: 7.0 quarters Tracked Q4 2024–Q2 2026 · 74.1% still held
- New positions
- 1
- Increased
- 5
- Decreased
- 3
- Closed
- 3
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
95.0%
Other/Unmapped
5.0%
Full portfolio 20 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| CGON CG Oncology, Inc. - Common stock | $80,393,115 | 21.94% | 1,131,500 | $3,813,157 | Up ×1 | ||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $61,581,856 | 16.80% | 1,673,420 | $31,493,764 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $40,001,341 | 10.92% | 2,144,844 | $14,413,352 | |||
| CADL Candel Therapeutics, Inc. - Common Stock | $36,028,864 | 9.83% | 3,497,948 | $18,818,960 | |||
| PBYI Puma Biotechnology Inc - Common Stock | $33,504,835 | 9.14% | 4,131,299 | $7,105,834 | |||
| JBIO Jade Biosciences, Inc. - Common Stock | $21,925,807 | 5.98% | 986,760 | $10,871,829 | Up ×1 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $19,102,000 | 5.21% | 643,381 | $6,305,140 | Down ×1 | ||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $14,831,964 | 4.05% | 1,518,113 | $13,228,773 | Up ×1 | ||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $12,948,913 | 3.53% | 2,839,674 | $1,192,663 | |||
| HELP Cybin Inc. - Common Stock | $10,181,159 | 2.78% | 1,540,266 | $2,787,882 | |||
| TARA Protara Therapeutics, Inc. - Common Stock | $6,693,079 | 1.83% | 1,752,115 | $-2,435,440 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $6,596,447 | 1.80% | 929,077 | $2,610,920 | Up ×1 | ||
| LONA LeonaBio, Inc. - Common Stock | $5,831,413 | 1.59% | 634,539 | $-691,648 | |||
| VSTM Verastem, Inc. - Common Stock | $5,612,164 | 1.53% | 1,469,153 | $-2,174,347 | |||
| WHWK Whitehawk Therapeutics, Inc. - Common Stock | $5,218,283 | 1.42% | 1,139,363 | $1,287,481 | |||
| QTTB Q32 Bio Inc. - Common Stock | $2,754,019 | 0.75% | 216,171 | $731,385 | Down ×3 | ||
| Unknown issuer (CUSIP: 29286X101) | $2,199,275 | 0.60% | 1,271,257 | Up ×1 | |||
| JSPR Jasper Therapeutics, Inc. - Class A Common Stock | $604,027 | 0.16% | 1,438,159 | $-638,086 | Up ×1 | ||
| BCAB BioAtla, Inc. - Common Stock | $447,645 | 0.12% | 108,126 | $-417,370 | Down ×1 | ||
| VYNE VYNE Therapeutics Inc. - Common Stock | $926 | 0.00% | 1,425 | $71 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: 29286X101) | $2,199,275 | 1,271,257 | 0.60% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| URGN | Price move only | +0 | +$31.5M |
| CADL | Price move only | +0 | +$18.8M |
| TRVI | Price move only | +0 | +$14.4M |
| JBIO | Bought more | +200K | +$10.9M |
| PBYI | Price move only | +0 | +$7.1M |
| BCAX | Trimmed | -1 | +$6.3M |
| CGON | Bought more | +999 | +$3.8M |
| HELP | Price move only | +0 | +$2.8M |
| AURA | Bought more | +333K | +$2.6M |
| TARA | Price move only | +0 | -$2.4M |
1 position hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| TERN | June 30, 2026 | 1,746,264 | $92,063,038 | No longer tracked |
| YMAB | Sept. 30, 2025 | 3,418,995 | $15,419,668 | No longer tracked |
| OPTN | June 30, 2025 | 422,814 | $3,877,202 | No longer tracked |
| CRDF | June 30, 2026 | 1,762,084 | $2,854,576 | -30.0% |
| MURA | Sept. 30, 2025 | 653,779 | $1,614,834 | No longer tracked |
| ACRV | March 31, 2026 | 405,237 | $976,622 | 64.7% |
| XFORXXXX | June 30, 2026 | 234,039 | $966,583 | No longer tracked |